Editorial: The Impact of Neurofilament Light Chain (NFL) Quantification in Serum and Cerebrospinal Fluid in Neurodegenerative Diseases

Front Neurosci. 2022 May 5:16:915115. doi: 10.3389/fnins.2022.915115. eCollection 2022.

Isabella Zanella^{1

2}, Hélène Blasco^{3

4}, Massimiliano Filosto⁵, Giorgio Biasiotto^{1

2}

¹ Department of Molecular and Translational Medicine, University of Brescia, Brescia, Italy.
² Clinical Chemistry Laboratory, Cytogenetics and Molecular Genetics Section, Diagnostic Department, ASST Spedali Civili di Brescia, Brescia, Italy.
³ Laboratoire de Biochimie et Biologie Moléculaire, CHRU de Tours, Tours, France.
⁴ Unité INSERM U1253, Université de Tours, Tours, France.
⁵ Department of Clinical and Experimental Sciences, NeMO-Brescia Clinical Center for Neuromuscular Diseases, University of Brescia, Brescia, Italy.

No abstract available

Keywords: axonal injury; biomarkers; neurodegeneration; neurofilament light chains (NFL); neurofilaments.

Publication types